Delivering Advanced Healthcare Solutions Through Research And Innovation To Improve The Quality Of Human Life
In The News
Thin-Strut Bioresorbable Vascular Scaffold Shows Promise
December 27, 2019

A next-generation bioresorbable scaffold (BRS) system - MeRes100, developed by Meril Life Sciences, with a low strut thickness of 100 micron. Explore the blog to learn more about MeRes100!
In The News
At The Heart Of Life, At The Heart Of Precision - Get Pumped Up About Heart Health
December 26, 2019

Meril has become the first Indian company in the world to make the Transcatheter Aortic Valve Replacement (TAVR) therapy available for patients. The human heart has four valves that are synchronized to open and close according to the heart’s rhythm.
In The News
Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations
December 25, 2019

Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for successful embolization of cranial arteriovenous shunts. There are few currently available LEAs.